This Advisory examines the role of genetic testing in assessing SUD vulnerability and outlines the current limitations of these technologies. 

This Practical Guide provides key considerations for guiding people in the appropriate use of 988 and 911. It offers practical steps for integrating crisis care into daily practice, real world scenarios, sample scripts, and de-escalation techniques.

Advancing Equity in Substance Use Disorder (SUD) Treatment Behavioral Health Resource reviews the literature on health disparities among racially and ethnically minoritized and other historically marginalized populations with SUD to develop insight on how to reduce disparities in SUD treatment systems, improve outcomes and access to treatment, and explore the role of evidence-based and promising practices and initiatives to enhance SUD health literacy on improving equity.

Countering Discrimination and Improving Recovery Supports Across Court, Corrections, and Reentry Settings highlights and addresses public misconceptions and misperceptions linking mental health and substance use conditions with crime rather than recognizing systemic barriers to accessing needed care.

Improving Data Collection & Reporting Resource Document Learning Collaborative Resource Document describes recommended strategies and best practices to help SSAs address each data quality characteristic.

Medications for Opioid Use Disorder: An Effective Treatment for Justice-Involved Persons Reentering the Community Brief Reference Document explores how Opioid Use Disorder (OUD) treatment for justice-involved individuals will help lower the overdose risk for people reentering the community. It discusses treatment barriers, strategies to address them, and key reentry services to promote the successful reintegration of people returning to the community from incarceration.

Housing Supports Recovery and Well-Being: Definitions and Shared Values summarizes the role that housing plays in supporting recovery for recovery and housing leaders. It describes two common models, recovery housing and supportive housing, and emphasizes the importance of promoting choice and ensuring equitable access to different models.

Mobile Medication Units and Health Clinics Issue Brief demonstrates how these models can provide better access in communities where obstacles to receiving care exist and can support continuity of services, thus serving an important role in addressing the opioid crisis; highlights efforts in two states; and provides recommendations and lessons learned for offering mobile services.

Innovative and Holistic Programs that Offer Medications for Opioid Use Disorder to Pregnant and Parenting Women Issue Brief highlights two SAMHSA-funded grant programs—E-MOMS and KS HEART—to illustrate the implementation of critical service elements for women’s Substance Use Disorder/Opioid Use Disorder (SUD/OUD) treatment in two states.

The Drug Abuse Warning Network (DAWN) National Estimates from Drug-Related Emergency Department Visits, 2023 report provides weighted national estimates. The frequency of substance-related visits increased by 5.8 percent compared to estimates in 2022. Rates of all substance-related ED visits from participating hospitals were highest among individuals with the following characteristics: males (2,668 per 100,000), individuals who were not Hispanic or Latino (2,391 per 100,000), and Black individuals, after accounting for the underlying population (4,053 per 100,000 versus 1,736 per 100,000 in the next highest subpopulation). The top substances reported were alcohol, cannabis, opioids, methamphetamines, cocaine, and benzodiazepines.